Formycon AG

Formycon AG is a leading independent developer of high-quality biopharmaceutical medicines, specialising in the development of biosimilars. The company focuses on providing innovative treatment solutions in ophthalmology, immunology, and various other chronic diseases. Their extensive activities encompass the complete pharmaceutical development process, from initial research and development through to regulatory approval.

Services include:
- Development of biosimilars
- Clinical development
- Regulatory affairs
- Project management
- Consulting services for pharmaceutical companies
- Quality assurance and control
- Manufacturing support

Formycon AG is committed to advancing healthcare through the development of biopharmaceuticals aimed at improving patient outcomes. To learn more about their offerings, visit formycon.com.